Fragile X Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Fragile X Syndrome, including details on symptoms, treatment, heritability, diagnosis.

Volume 7 (2011), Issue 3 (March)

1. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome.
   Mol Autism, 2(1): 2. [Abstract] [Full-text]
2. Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment.
   Brain Res, 1380: 106-19. [Abstract] [Full-text]
3. Open-label riluzole in fragile X syndrome.
   Brain Res, 1380: 264-70. [Abstract] [Full-text]
4. Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment.
   Brain Res, 1380: 106-19. [Abstract] [Full-text]
5. Open-label riluzole in fragile X syndrome.
   Brain Res, 1380: 264-70. [Abstract] [Full-text]
6. Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment.
   Brain Res, 1380: 106-19. [Abstract] [Full-text]
7. Open-label riluzole in fragile X syndrome.
   Brain Res, 1380: 264-70. [Abstract] [Full-text]
8. Genetic-background modulation of core and variable autistic-like symptoms in FMR1 knock-out mice.
   PLoS One, 6(2): e17073. [Abstract] [Full-text]
9. A non-canonical start codon in the Drosophila fragile X gene yields two functional isoforms.
   Neuroscience. [Abstract] [Full-text]
10. Genetic-background modulation of core and variable autistic-like symptoms in FMR1 knock-out mice.
    PLoS One, 6(2): e17073. [Abstract] [Full-text]
11. Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders.
    Molecules, 16(3): 2097-106. [Abstract] [Full-text]
12. Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders.
    Molecules, 16(3): 2097-106. [Abstract] [Full-text]
13. Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.
    Molecules, 16(3): 2097-106. [Abstract] [Full-text]
14. Enacting genetic responsibility: experiences of mothers who carry the fragile X gene.
    Sociol Health Illn, 33(3): 420-33. [Abstract] [Full-text]
15. Enacting genetic responsibility: experiences of mothers who carry the fragile X gene.
    Sociol Health Illn, 33(3): 420-33. [Abstract] [Full-text]
16. Enacting genetic responsibility: experiences of mothers who carry the fragile X gene.
    Sociol Health Illn, 33(3): 420-33. [Abstract] [Full-text]
17. Neuroanatomical differences in toddler boys with fragile x syndrome and idiopathic autism.
    Arch Gen Psychiatry, 68(3): 295-305. [Abstract] [Full-text]
18. Neuroanatomical differences in toddler boys with fragile x syndrome and idiopathic autism.
    Arch Gen Psychiatry, 68(3): 295-305. [Abstract] [Full-text]
19. Neuroanatomical differences in toddler boys with fragile x syndrome and idiopathic autism.
    Arch Gen Psychiatry, 68(3): 295-305. [Abstract] [Full-text]
20. Fragile X Syndrome therapy: to respond or not to respond may be a matter of methylation.
    Clin Genet. [Abstract] [Full-text]
21. Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice.
    Neurobiol Learn Mem. [Abstract] [Full-text]
22. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Biochem Pharmacol. [Abstract] [Full-text]
23. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.
    Neurobiol Dis. [Abstract] [Full-text]
24. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.
    Neurobiol Dis. [Abstract] [Full-text]
25. Heads-up: New roles for the fragile X mental retardation protein in neural stem and progenitor cells.
    Genesis. [Abstract] [Full-text]
26. Expressive morphosyntax in boys with Fragile X syndrome with and without autism spectrum disorder.
    Int J Lang Commun Disord, 46(2): 216-30. [Abstract] [Full-text]
27. Heads-up: New roles for the fragile X mental retardation protein in neural stem and progenitor cells.
    Genesis. [Abstract] [Full-text]
28. Expressive morphosyntax in boys with Fragile X syndrome with and without autism spectrum disorder.
    Int J Lang Commun Disord, 46(2): 216-30. [Abstract] [Full-text]
29. Heads-up: New roles for the fragile X mental retardation protein in neural stem and progenitor cells.
    Genesis. [Abstract] [Full-text]
30. Expressive morphosyntax in boys with Fragile X syndrome with and without autism spectrum disorder.
    Int J Lang Commun Disord, 46(2): 216-30. [Abstract] [Full-text]
31. Fragile X Syndrome therapy: to respond or not to respond may be a matter of methylation.
    Clin Genet. [Abstract] [Full-text]
32. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Biochem Pharmacol. [Abstract] [Full-text]
33. A nonsense mutation in FMR1 causing fragile X syndrome.
    Eur J Hum Genet, 19(4): 489-91. [Abstract] [Full-text]
34. Fragile X Syndrome therapy: to respond or not to respond may be a matter of methylation.
    Clin Genet. [Abstract] [Full-text]
35. A nonsense mutation in FMR1 causing fragile X syndrome.
    Eur J Hum Genet, 19(4): 489-91. [Abstract] [Full-text]
36. A nonsense mutation in FMR1 causing fragile X syndrome.
    Eur J Hum Genet, 19(4): 489-91. [Abstract] [Full-text]
37. Reprint of: Impaired fixation to eyes following amygdala damage arises from abnormal bottom-up attention.
    Neuropsychologia, 49(4): 589-95. [Abstract] [Full-text]
38. Reprint of: Impaired fixation to eyes following amygdala damage arises from abnormal bottom-up attention.
    Neuropsychologia, 49(4): 589-95. [Abstract] [Full-text]
39. Repeat Associated Non-ATG Translation Initiation: One DNA, Two Transcripts, Seven Reading Frames, Potentially Nine Toxic Entities!
    PLoS Genet, 7(3): e1002018. [Abstract] [Full-text]
40. Implicit procedural learning in fragile X and Down syndrome.
    J Intellect Disabil Res, 55(5): 521-8. [Abstract] [Full-text]
41. Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice.
    Neurobiol Learn Mem. [Abstract] [Full-text]
42. A non-canonical start codon in the Drosophila fragile X gene yields two functional isoforms.
    Neuroscience. [Abstract] [Full-text]
43. Repeat Associated Non-ATG Translation Initiation: One DNA, Two Transcripts, Seven Reading Frames, Potentially Nine Toxic Entities!
    PLoS Genet, 7(3): e1002018. [Abstract] [Full-text]
44. Implicit procedural learning in fragile X and Down syndrome.
    J Intellect Disabil Res, 55(5): 521-8. [Abstract] [Full-text]
45. Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice.
    Neurobiol Learn Mem. [Abstract] [Full-text]
46. Implicit procedural learning in fragile X and Down syndrome.
    J Intellect Disabil Res, 55(5): 521-8. [Abstract] [Full-text]
47. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
    Learn Mem, 18(4): 207-20. [Abstract] [Full-text]
48. Distribution of CGG/GCC Repeats at the FMR1 and FMR2 Genes in an Indian Population with Mental Retardation of Unknown Etiology.
    Genet Test Mol Biomarkers, 15(4): 281-4. [Abstract] [Full-text]
49. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
    Learn Mem, 18(4): 207-20. [Abstract] [Full-text]
50. Distribution of CGG/GCC Repeats at the FMR1 and FMR2 Genes in an Indian Population with Mental Retardation of Unknown Etiology.
    Genet Test Mol Biomarkers, 15(4): 281-4. [Abstract] [Full-text]
51. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
    Learn Mem, 18(4): 207-20. [Abstract] [Full-text]
52. Distribution of CGG/GCC Repeats at the FMR1 and FMR2 Genes in an Indian Population with Mental Retardation of Unknown Etiology.
    Genet Test Mol Biomarkers, 15(4): 281-4. [Abstract] [Full-text]
53. An Indirect Examination of the Function of Problem Behavior Associated with Fragile X Syndrome and Smith-Magenis Syndrome.
    J Autism Dev Disord. [Abstract] [Full-text]
54. An Indirect Examination of the Function of Problem Behavior Associated with Fragile X Syndrome and Smith-Magenis Syndrome.
    J Autism Dev Disord. [Abstract] [Full-text]
55. An Indirect Examination of the Function of Problem Behavior Associated with Fragile X Syndrome and Smith-Magenis Syndrome.
    J Autism Dev Disord. [Abstract] [Full-text]
56. White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
57. Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.
    Neuropsychology. [Abstract] [Full-text]
58. High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
    Genet Med. [Abstract] [Full-text]
59. White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
60. Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.
    Neuropsychology. [Abstract] [Full-text]
61. High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
    Genet Med. [Abstract] [Full-text]
62. Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.
    Neuropsychology. [Abstract] [Full-text]
63. High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
    Genet Med. [Abstract] [Full-text]

© 2005-2012 Fragile X Syndrome Research Today. All Rights Reserved.